- Home
- News & Events
- In the News
In the News
91黑料 experts frequently author or contribute to industry trade press.
Filter media
Filter media articles by either clicking within the ‘Category’ drop-down list, or begin typing which will automatically match to the nearest available category. Note - not all categories will display results if selecting a particular year.
-
91黑料’s Chief Medical and Innovation Officer, Greg Licholai, explores this topic in his recent column in Forbes.
-
Travis Caudill, VP Feasibility & Clinical Informatics, offers his insights on how .
Innovations in Pharmaceutical Technology, December 2022, pages 24-25. Samedan Ltd
-
considers the current issues around the applicability of Machine Learning Models.
Bennett, M. Balusu, J., Hayes, K., & Klecyzk, E. J., The Silent Problem- Machine Learning Model Failure - How to Diagnose and Fix Ailing Machine Learning Models. Cornell University ArxIV.
-
Michael Philips considers .
-
Louisa Roberts, VP of Corporate Development and Partnerships, considers .
-
Michael Phillips and Kevin Rooney discuss .
This article is taken from Innovations in Pharmaceutical Technology Autumn/Winter 2021, pages 39-41. Samedan Ltd
-
Gerard Quinn, VP of IT Innovation & Informatics, offers insights on (pages 16-17).
-
AI in Life Sciences – Covid pushes AI driven clinical trials and drug manufacturing into the limelight
91黑料’s CIO, Tom Leary discusses the challenges to patient recruitment during the COVID pandemic and how big data, combined with advanced AI algorithms processing has the potential to reduce trial costs.
-
In a wide-ranging interview with , 91黑料 CIO, Tom O’Leary highlights the role of and the steps that still need to be taken to better match .
-
91黑料's CIO Tom O'Leary provides expert commentary on in this January 2020 Bio IT World Article.